Wednesday 12 March 2025
A new study has shed light on the potential for early patient discharge after a type of radiation therapy called Boron Neutron Capture Therapy (BNCT). This innovative treatment uses low-energy neutrons to target and destroy cancer cells, while minimizing damage to surrounding tissues.
Researchers used advanced computer simulations to evaluate the activation of patients’ bodies during BNCT treatments. They found that even under conservative assumptions, patient activation does not pose a significant radiological concern for early discharge. In fact, their findings suggest that patients could be released as soon as 15 minutes after treatment.
BNCT is a complex procedure that requires careful planning and execution. Patients are administered a special drug containing boron-10, which selectively accumulates in cancer cells. The therapy then involves irradiating the patient with low-energy neutrons, causing the boron to capture these particles and release high-energy radiation that destroys nearby cancer cells.
To assess the potential for early discharge, researchers used a sophisticated computer model of the adult human body. They simulated various scenarios, including different irradiation times and positions, to estimate the amount of radioactive material produced in each case.
The results showed that even after two hours of irradiation – a relatively long treatment time – patient activation was still within acceptable limits. This suggests that patients could be released shortly after treatment without posing a significant risk to themselves or others.
One key finding was the importance of shielding to protect the patient’s body during irradiation. By reducing the amount of neutron flux reaching certain tissues and organs, researchers can minimize radiation exposure and reduce the need for lengthy hospital stays.
The study also highlighted the need for dedicated facilities to handle patients’ excreta after treatment. This is because the boron-10 drug used in BNCT can be released into urine and feces, posing a potential risk to others if not properly managed.
While this research focuses on the feasibility of early discharge, it also underscores the importance of comprehensive radiation protection planning for BNCT facilities. By considering factors like patient positioning, shielding, and waste management, researchers can ensure that this innovative therapy is both effective and safe.
As scientists continue to refine BNCT techniques and develop new technologies, these findings will play a crucial role in shaping the future of cancer treatment. By exploring the potential for early discharge, researchers are one step closer to making this promising therapy available to more patients worldwide.
Cite this article: “Early Discharge Feasible After Boron Neutron Capture Therapy”, The Science Archive, 2025.
Boron Neutron Capture Therapy, Radiation Therapy, Cancer Treatment, Patient Discharge, Neutron Flux, Shielding, Radiation Protection, Waste Management, Boron-10, Computer Simulations.
